Egypt, Bechtel Discuss Means of Bolstering Cooperation

The meeting held between Molla and Jones in Cairo on Tuesday, May 12, 2021.
The meeting held between Molla and Jones in Cairo on Tuesday, May 12, 2021.
TT

Egypt, Bechtel Discuss Means of Bolstering Cooperation

The meeting held between Molla and Jones in Cairo on Tuesday, May 12, 2021.
The meeting held between Molla and Jones in Cairo on Tuesday, May 12, 2021.

Egypt’s Minister of Petroleum and Mineral Resources Tarek el-Molla discussed with President for Regions and Corporate Relations at Bechtel Corporation Stuart Jones means of bolstering bilateral cooperation on oil and joint projects.

Both sides also reviewed the latest developments in the Red Sea Petrochemical Complex project at the Suez Canal Economic Zone (SCZone), with investments estimated at about $7 billion.

They tackled the proposed action plan for the project’s implementation, in light of the principles agreement signed with the US company and the results of detailed feasibility studies for the project.

The US ambassador to Cairo, Jonathan Cohen, also attended the meeting, during which both sides signed a contract to assign the land on which the project will be built.

The complex project comes in line with the ministry’s strategy to expand value-added projects in the petrochemical industry and increase the production capacity of petroleum and petrochemical products to cover the needs of the local market and export the excess, Molla explained.

He stressed the importance of bilateral coordination to expedite the project’s implementation.

The participation of major international companies in the Gas Industry Advisory Committee (GIAC) at the East Mediterranean Gas Forum (EMGF), including Bechtel, indicates the importance of this committee and its role in liquefied natural gas (LNG) activity, Molla noted.

He pointed out that the GIAC provides the opportunity to define common goals and give confidence to all companies wishing to invest in the region by creating a balanced environment for investments.

Cohen, for his part, said the US-Egyptian relations are distinguished and historic in various fields.

He said the US is willing to bolster the investments of US companies in the fields of oil, gas and petrochemicals in Cairo.

Meanwhile, Jones affirmed that Egypt succeeded in providing an attractive investment environment for foreign investors, pointing to its increasingly leading role in the region, especially after launching the EMGF.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.